New York, New York (NetworkNewsWire) – It is no secret that the
legal marijuana market is exploding in North America. Analysts have
predicted the cannabis market in the United States could reach
$24.1 billion by 2025, and recent polls indicate 61 percent of
Americans now believe marijuana use should be federally
legalized1. Measures are currently being taken in Canada
to legalize recreational marijuana by 2018. On a global scale, the
worldwide cannabis market has been projected to reach up to $55.8
billion USD by 20252. A wide variety of players have
been scrambling to stake a claim in this booming market, whether
through directly handling the marijuana plant or by serving those
who do. Unique standouts in this burgeoning market include
ChineseInvestors.com, Inc. (CIIX) (CIIX
Profile), CV Sciences, Inc. (CVSI),
Terra Tech Corp. (TRTC), Medical
Marijuana, Inc. (MJNA) and Hemp, Inc.
(HEMP).
ChineseInvestors.com, Inc. (CIIX) is tapping
into a profitable niche market as it serves Chinese-speaking
consumers throughout the world and aims to become the largest
publicly traded Chinese medical marijuana company.
CIIX is focused on the research, development and distribution of
legalized cannabidiol (CBD) to the global Chinese-speaking
community. Already one of the fastest growing segments in the U.S.
hemp and legal marijuana industry, application of CBD is also
gaining traction in China. CIIX operates an online store in the
free trade zone of Shanghai, China, where CBD sales are legal,
though marijuana use is not. CIIX also recently established,
through its wholly owned subsidiary ChineseHempOil.com, Inc., a
club-style Hemp Education Center in the company’s home market of
San Gabriel, California, to educate interested parties regarding
the potential health benefits of non-industrial hemp and
hemp-derived CBD (http://nnw.fm/oV4Ga).
CIIX recently engaged Arizona-based Launch Haus LLC, a holding
company that specializes in digital direct-to-consumer marketing
and product branding, to aid in growing the company’s worldwide
sales of hemp-based CBD products (http://nnw.fm/RVz21). In June 2017, the company
further incorporated CBD Biotechnology Inc. in British Columbia,
Canada, as part of its efforts to enter the medical marijuana
market there. Medical marijuana has been federally legal in Canada
since 2001, and the Canadian government is now making strides
toward the national legalization of recreational marijuana.
“The incorporation of CBD Biotechnology Inc. is a promising step
forward toward CIIX’s goals to enter the medical marijuana
industry. Through its expansion into Canada, CIIX aims to generate
significant revenues through sales of CBD-based health products,
while helping the nearly one million Chinese in Canada to improve
their overall health,” Warren Wang, founder and CEO of CIIX, stated
in a news release (http://nnw.fm/9y0Dc).
In December 2016, CIIX entered into a wholesale agreement with a
well-known CBD health brand and formally launched a website for its
subsidiary, ChineseCBDoil.com, which went live in January 2017.
This launch marked the introduction of the world’s first Chinese
language online store for CBD health products. At that same time,
CIIX debuted the first Chinese language Yelp-style social media app
where users can discuss and review cannabis services and products,
as well as find locations of dispensaries.
The company has built a widespread user base of more than
100,000 individuals, and it continues its focus on investing in
both the R&D and distribution of CBD products. Corporate
objectives include plans to further its study into the
effectiveness of CBD for medicinal purposes in an effort to become
the first company in China to employ CBD oil as a means of
mitigating the suffering of epilepsy and Alzheimer’s patients. The
application period for such new drugs in China is only two to four
years—significantly shorter than the time it often takes companies
to fulfill regulatory requirements in the United States.
As CIIX continues to penetrate new markets, others are taking
notice. Consilium Global Research recently projected a CAGR of
almost 100 percent for CIIX through 2026 (http://nnw.fm/e5EiK), predicting revenues of up to
$14.8 million.
Another standout cannabis player is CV Sciences, Inc.
(CVSI), which operates two distinct divisions:
pharmaceuticals and consumer products. The company’s
pharmaceuticals division is focused on the development and
commercialization of novel therapeutics that utilize synthetic CBD.
Its consumer products division manufactures, markets and sells
plant-based CBD products to various market sectors, distributing
these products nationally through the Internet as well as through
health food stores and health care provider offices. The company’s
divisions are backed by a medical and scientific advisory board, as
well as state-of-the-art production facilities, and its consumer
products are supported by formal safety reviews, increasing case
reports and recommendations from physicians. CV Sciences is
pursuing FDA approval for drugs with particular indications,
featuring CBD as the active pharmaceutical ingredient, and the
company has achieved promising preclinical results. CV Sciences’
initial drug candidate is CVSI-007, a chewing gum that contains
nicotine and synthetic CBD to aid individuals in quitting tobacco
use and escaping addiction.
Vertically integrated, cannabis-focused agricultural company
Terra Tech Corp. (TRTC) is another interesting
marijuana play, operating through various subsidiaries including
Blüm, IVXX Inc., Edible Garden and MediFarm LLC. Three of these
subsidiaries are cannabis-focused. Blüm operates retail and medical
cannabis facilities that deliver high-quality medical marijuana
products to patients seeking alternative treatments for chronic
medical conditions, as well as premium cannabis for Nevada’s
adult-use market. IVXX, Inc. produces cannabis-extracted products
for regulated medical marijuana dispensaries throughout California
and adult-use and medical cannabis dispensaries in Nevada. Under
the IVXX brand, Terra Tech recently filed a patent with the U.S.
Patent and Trademark Office for cannabis-infused rolling papers,
which are anticipated to be released in 2018. The company’s
MediFarm LLC subsidiaries are focused on medical and adult-use
cultivation and permitting businesses in Nevada.
Medical Marijuana, Inc. (MJNA) stood out as the
first company to offer hemp-based CBD products in the United
States. The company accomplished this by offering cannabis-derived
products that exploit the health properties of non-psychoactive
cannabinoids, like CBD, which are legal in the U.S. The company
uses cannabis varieties (hemp) that are grown outside the U.S. and
either have very low tetrahydrocannabinol levels or no THC at all.
Carefully cultivated CBD hemp oil and hemp oil products, offering a
full range of phytocannabinoids and high CBD content, are created
and then imported into the U.S. In addition to being the first
publicly traded cannabis company in the U.S., MJNA has stood out as
the first company to bring legal medical cannabis products to
Mexico, Brazil, Puerto Rico and Paraguay; the first company to
offer government-subsidized botanical cannabis-based products; the
first company to deliver prescription CBD products to treat
epilepsy, Alzheimer’s, Parkinson’s, chronic pain and migraine; the
first company to deliver cannabis brands across U.S. state lines
and international borders; and more.
Hemp, Inc. (HEMP) is an industrial hemp-focused
company that aims to become a leader in the industrial hemp market
through a portfolio of synergistic businesses formed through
purchase, acquisition or joint venture with companies across
various hemp industry sectors. Hemp, Inc.’s mission is to offer
green solutions through its hemp products, which are eco-friendly
and can often be used in place of petroleum-based products. The
American hemp fiber industry has been estimated at over $500
million, and a hemp crop is known to be more economical and
ecological than cotton or trees, reducing water, energy and
pesticide use. Hemp, Inc.’s products include DrillWall lost
circulation material for oil field drilling application and
Spill-Be-Gone and SpillSuck for large- and small-scale oil spill
cleanup. The company is also developing SpillMaster for offshore
oil spill cleanup.
For investors seeking play in the cannabis market, the mentioned
companies offer intriguing and varied opportunities. As this
burgeoning market continues its forward drive, these companies may
provide promising opportunities to climb aboard.
Editorial Sources:
1) CBS News: http://nnw.fm/5Qh2x
2) Grand View Research: http://nnw.fm/Gf3dQ
For more on CIIX please visit: ChineseInvestors.com (CIIX) or www.ChineseInvestors.com
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides
(1) access to our news aggregation and syndication servers, (2)
NetworkNewsBreaks that summarize corporate news and
information, (3) enhanced press release services, (4) social media
distribution and optimization services, and (5) a full array of
corporate communication solutions. As a multifaceted financial news
and content distribution company with an extensive team of
contributing journalists and writers, NNW is uniquely positioned to
best serve private and public companies that desire to reach a wide
audience of investors, consumers, journalists and the general
public. NNW has an ever-growing distribution network of more than
5,000 key syndication outlets across the country. By cutting
through the overload of information in today’s market, NNW brings
its clients unparalleled visibility, recognition and brand
awareness. NNW is where news, content and information converge.
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Please see full terms of use and disclaimers on the
NetworkNewsWire website applicable to all content provided by NNW,
wherever published or re-published: http://NNW.fm/Disclaimer
DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by NNW are
solely those of NNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable NNW for any investment
decisions by their readers or subscribers. NNW are a news
dissemination and financial marketing solutions provider and are
NOT registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, NNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer’s filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer’s securities, including, but not
limited to, the complete loss of your investment.
NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. “Forward-looking statements” describe future expectations,
plans, results, or strategies and are generally preceded by words
such as “may”, “future”, “plan” or “planned”, “will” or “should”,
“expected,” “anticipates”, “draft”, “eventually” or “projected”.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company’s annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and NNW undertake no
obligation to update such statements.
Source:
NetworkNewsWire
Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Medical Marijuana (PK) (USOTC:MJNA)
Historical Stock Chart
From Sep 2023 to Sep 2024